1. Home
  2. NRSN vs CREX Comparison

NRSN vs CREX Comparison

Compare NRSN & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • CREX
  • Stock Information
  • Founded
  • NRSN 2017
  • CREX N/A
  • Country
  • NRSN Israel
  • CREX United States
  • Employees
  • NRSN N/A
  • CREX N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • CREX EDP Services
  • Sector
  • NRSN Health Care
  • CREX Technology
  • Exchange
  • NRSN Nasdaq
  • CREX Nasdaq
  • Market Cap
  • NRSN 29.8M
  • CREX 33.2M
  • IPO Year
  • NRSN 2021
  • CREX N/A
  • Fundamental
  • Price
  • NRSN $0.98
  • CREX $2.63
  • Analyst Decision
  • NRSN Buy
  • CREX Strong Buy
  • Analyst Count
  • NRSN 2
  • CREX 1
  • Target Price
  • NRSN $14.00
  • CREX $6.00
  • AVG Volume (30 Days)
  • NRSN 202.0K
  • CREX 80.3K
  • Earning Date
  • NRSN 12-17-2025
  • CREX 11-12-2025
  • Dividend Yield
  • NRSN N/A
  • CREX N/A
  • EPS Growth
  • NRSN N/A
  • CREX N/A
  • EPS
  • NRSN N/A
  • CREX N/A
  • Revenue
  • NRSN N/A
  • CREX $44,323,000.00
  • Revenue This Year
  • NRSN N/A
  • CREX N/A
  • Revenue Next Year
  • NRSN N/A
  • CREX $24.88
  • P/E Ratio
  • NRSN N/A
  • CREX N/A
  • Revenue Growth
  • NRSN N/A
  • CREX N/A
  • 52 Week Low
  • NRSN $0.80
  • CREX $1.28
  • 52 Week High
  • NRSN $2.60
  • CREX $4.00
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 37.32
  • CREX 42.92
  • Support Level
  • NRSN $0.89
  • CREX $2.45
  • Resistance Level
  • NRSN $0.97
  • CREX $2.96
  • Average True Range (ATR)
  • NRSN 0.07
  • CREX 0.18
  • MACD
  • NRSN -0.01
  • CREX -0.05
  • Stochastic Oscillator
  • NRSN 26.22
  • CREX 23.65

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: